Zentalis Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Zentalis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Zentalis Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Zentalis Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $957k | 63k | 15.15 |
| 2023-09-30 | $5.0M | 249k | 20.06 |
| 2023-06-30 | $3.9M | 228k | 17.20 |
| 2023-03-31 | $3.9M | 228k | 17.20 |
| 2022-12-31 | $4.8M | 240k | 20.14 |
| 2022-09-30 | $4.9M | 226k | 21.66 |
| 2022-06-30 | $4.1M | 145k | 28.10 |
| 2022-03-31 | $6.0M | 130k | 46.14 |
| 2021-12-31 | $12M | 138k | 84.06 |
| 2021-09-30 | $1.4M | 20k | 66.64 |
| 2021-06-30 | $1.1M | 20k | 53.20 |
| 2021-03-31 | $764k | 18k | 43.39 |
| 2020-12-31 | $597k | 12k | 51.94 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas